InferX Corporation Introduces Predictive Analytics Application Solution for Multi-Billion Dollar LINUX and UNIX Market

STERLING, Va., Jan. 25, 2012 /PRNewswire/ -- InferX Corporation (OTCQB: NFRX), the technology leader in patented next generation distributed Predictive Analytics Products and Solutions, announced today that it has introduced its Distributed Data Analytics (D2A) platform to provide Advanced Predictive Analytics software and support services for the LINUX and UNIX Enterprise Marketplace.  This new development is exciting because InferX's D2A platform now provides numerous new features and enhancements facilitating improved predictive performance and scalability, and ease of deployment throughout multiple operating systems worldwide.

"InferX has introduced what we believe is a powerful new architecture to use a single code base for Windows and UNIX.  Corporations can now get the D2A based PA solutions across multiple operating systems simultaneously.  This expanded capability to run on non-Windows environments benefits enterprises that need flexibility, and interoperability.  The enhanced D2A technology now has broadly significant appeal to UNIX based enterprises and as such will expand InferX's customer base, boost direct and indirect channel reach and depth, gaining new significant market sectors for our PA Solutions," said InferX's CTO Dr. Jerzy Bala.

InferX's powerful technology can now deliver its unique PA solution to the market and most importantly without compromising customers' operating environments or having to move the data.  This technology enhancement also includes the addition of a complete set of D2A's Application Programming Interfaces (APIs).  This greatly expanded D2A APIs capability provides an open architecture for deploying InferX's distributed data analytics solutions within customers' native applications.

"We believe that the enhancements to InferX's D2A platform make the application of Predictive Analytics technology a significant game changer for healthcare and financial corporations worldwide.  Our enhanced technology allows clients to make comparisons, identify "unknown unknowns" analyze mission requirements and evaluate key organizational measurement variables across multiple operating systems simultaneously.  At a time of tight budget constraints, InferX provides enterprise customers the capability of improving enterprise-level operational and planning processes, through the use of advanced analytics and without having to move the data.  I am very proud of our team's innovative technology efforts, while meeting aggressive product development milestones," said Vijay Suri, President & CEO of InferX Corp.

For more information contact Stan Altschuler, (212) 838-1510, Investor Relations, Strategic Universal Advisors.

About InferX Corporation

InferX is the market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support — all without the need to move data. InferX is headquartered in Sterling, VA.

Certain statements above, in press releases and NFRX officials oral statements are "Forward-Looking Statements" (FLS) according to the Private Securities Litigation Reform Act of 1995 (the "Act"). FLS include statements predictive in nature, depending upon or referring to future events / conditions, including words like "believes," "anticipates," "intends," "plans," "expects," and similar expressions.  Statements concerning future financial performance (revenues, earnings, and growth rates), ongoing business strategies / prospects, and future actions, which may be provided by management, are also FLS as defined by the Act. The actual and any future results, performance or achievements of the Company, expressed or implied, may be materially different and vary significantly for different reporting periods due to FLS that involve known and unknown risks and other factors.  See InferX's 10-K for 12/31/10 for a discussion of those risks.  Management believes that the assumptions made and expectations reflected in the FLS are reasonable.  There is no assurance that the underlying assumptions will prove to be correct and the actual future results may be different from expectations expressed above.  These statements are not guarantees of future performance.  NFRX has no specific intention to update these statements.

©2012 InferX Corporation. All rights reserved. All trademarks and company names mentioned are the property of their respective owners.

SOURCE InferX Corporation